Generated: December 18, 2017
DrugPatentWatch Database Preview
Atomoxetine hydrochloride - Generic Drug Details
« Back to Dashboard
What are the generic sources for atomoxetine hydrochloride and what is the scope of atomoxetine hydrochloride freedom to operate?
is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Teva Pharms Usa, Zydus Pharms Usa Inc, and Lilly, and is included in six NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
There are fourteen drug master file entries for atomoxetine hydrochloride. Fourteen suppliers are listed for this compound. There are seven tentative approvals for this compound.
Summary for atomoxetine hydrochloride
Pharmacology for atomoxetine hydrochloride
Medical Subject Heading (MeSH) Categories for atomoxetine hydrochloride
Tentative approvals for ATOMOXETINE HYDROCHLORIDE
|Lilly||STRATTERA||atomoxetine hydrochloride||CAPSULE;ORAL||021411-007||Feb 14, 2005||AB||RX||Yes||No||► Subscribe||► Subscribe||Y||► Subscribe|
|Lilly||STRATTERA||atomoxetine hydrochloride||CAPSULE;ORAL||021411-002||Nov 26, 2002||AB||RX||Yes||No||► Subscribe||► Subscribe||Y||► Subscribe|
|Glenmark Pharms Ltd||ATOMOXETINE HYDROCHLORIDE||atomoxetine hydrochloride||CAPSULE;ORAL||079019-004||May 30, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Glenmark Pharms Ltd||ATOMOXETINE HYDROCHLORIDE||atomoxetine hydrochloride||CAPSULE;ORAL||079019-006||May 30, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Zydus Pharms Usa Inc||ATOMOXETINE HYDROCHLORIDE||atomoxetine hydrochloride||CAPSULE;ORAL||079017-002||Sep 17, 2010||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Aurobindo Pharma Ltd||ATOMOXETINE HYDROCHLORIDE||atomoxetine hydrochloride||CAPSULE;ORAL||079016-003||May 30, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Zydus Pharms Usa Inc||ATOMOXETINE HYDROCHLORIDE||atomoxetine hydrochloride||CAPSULE;ORAL||079017-006||Sep 17, 2010||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Lilly||STRATTERA||atomoxetine hydrochloride||CAPSULE;ORAL||021411-008||Feb 14, 2005||AB||RX||Yes||No||► Subscribe||► Subscribe||Y||► Subscribe|
|Apotex Inc||ATOMOXETINE HYDROCHLORIDE||atomoxetine hydrochloride||CAPSULE;ORAL||078983-003||May 30, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Apotex Inc||ATOMOXETINE HYDROCHLORIDE||atomoxetine hydrochloride||CAPSULE;ORAL||078983-004||May 30, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: atomoxetine hydrochloride
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.